Sign in

CIK 0001787400

  • Non-accelerated filer
  • Smaller reporting company

Nkarta, Inc.

Sign in to watch
Ticker
NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474515206
Phone
+1 925-407-1049
Business address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Sr. VP, Technical Operations sold 4,140 shares at $15.00 ($62,100)
  6. 4 Open-market buy Director bought 1,333,333 shares at $15.00 ($19,999,995)
  7. 4 Open-market buy Director bought 2,200,000 shares at $15.00 ($33,000,000)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Chief Executive Officer acquired 41,900 shares (grant or award)
  11. 4 Grant or award Mahmood Nadir acquired 12,800 shares (grant or award)
  12. 4 Grant or award Chief Medical Officer acquired 12,800 shares (grant or award)
  13. 4 Grant or award Chief Legal Officer acquired 12,800 shares (grant or award)
  14. 4 Grant or award Chief Scientific Officer acquired 12,800 shares (grant or award)
  15. 4 Grant or award Sr. VP, Technical Operations acquired 5,300 shares (grant or award)
  16. 4 Open-market sale Sr. VP, Technical Operations sold 4,140 shares at $15.64 ($64,750)
  17. 4 Open-market sale Chief Executive Officer sold 8,500 shares at an average $27.18 ($231,051)
  18. 4 Open-market sale Brandenberger Ralph sold 4,140 shares at $32.08 ($132,811)
  19. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $37.28 ($372,800)
  20. 4 Open-market sale Chief Scientific Officer sold 3,600 shares at $31.53 ($113,508)

Page 7 of 11 · 218 filings